Improving Clinical Trial Performance Through Central eSource

A leading global pharmaceutical company launched an initiative to enhance site performance across its worldwide clinical studies. With numerous large-scale trials spanning multiple countries and therapeutic areas, the company sought innovative solutions to reduce site burden, streamline data collection, and drive more efficient, high-quality trial execution.

During a global Alzheimer’s disease study, the sponsor noted a compelling trend: 43% of participating sites were using CRIO eSource to capture source data electronically. Not only did these sites represent a significant portion of the total study population, but they also ranked among the trial’s top performers in terms of data quality, compliance, and operational efficiency.

Recognizing the potential impact, the sponsor engaged with CRIO to explore how eSource technology could be implemented more broadly — aiming to replicate these performance gains across future studies and achieve a more consistent, efficient, and site-friendly clinical trial model.